EPP Pathophysiology and Light Toxicity

Why visible-light exposure becomes clinically central in protoporphyria.

The Disease Context

The afamelanotide story only becomes clinically coherent when EPP is treated as the central use case. This unit explains why light tolerance is not a cosmetic endpoint here.

EPP Pathophysiology Cascade

Trace the full cascade from ferrochelatase deficiency through protoporphyrin IX accumulation to phototoxic tissue damage. Click each stage to see how the pathway breaks down in EPP.

interactive EPP pathophysiology cascade

Knowledge Check

Test the disease-context essentials.

Practice

Apply the pathophysiology before moving into trial interpretation.